Literature DB >> 18534908

Turning NF-kappaB and IRFs on and off in DC.

Tsuneyasu Kaisho1, Takashi Tanaka.   

Abstract

Dendritic cells (DCs) produce an array of cytokines after detecting various immune adjuvants through pattern recognition receptors (PRRs). PRR signaling leads to activation of transcription factors such as NF-kappaB or interferon regulatory factors (IRFs) but after activation must be attenuated to avoid immunopathology and to maintain tissue homeostasis. IkappaB kinase family members, originally identified as classical NF-kappaB activators, are now found to be broadly and crucially involved in PRR signaling in a member-specific manner. Furthermore, a new mechanism for NF-kappaB downregulation is emerging that involves the degradation of active NF-kappaB by the nuclear ubiquitin-proteasome system. Here we review new aspects of NF-kappaB and IRF regulation chiefly in DCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18534908     DOI: 10.1016/j.it.2008.03.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  35 in total

Review 1.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

2.  HSCARG regulates NF-kappaB activation by promoting the ubiquitination of RelA or COMMD1.

Authors:  Min Lian; Xiaofeng Zheng
Journal:  J Biol Chem       Date:  2009-05-11       Impact factor: 5.157

Review 3.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

4.  The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3.

Authors:  Yanxing Yu; Gary S Hayward
Journal:  Immunity       Date:  2010-12-14       Impact factor: 31.745

5.  TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.

Authors:  Kevin M Nickerson; Sean R Christensen; Jonathan Shupe; Michael Kashgarian; Daniel Kim; Keith Elkon; Mark J Shlomchik
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

6.  An NF-kappaB-dependent role for JunB in the induction of proinflammatory cytokines in LPS-activated bone marrow-derived dendritic cells.

Authors:  Tiphanie Gomard; Henri-Alexandre Michaud; Denis Tempé; Kevin Thiolon; Mireia Pelegrin; Marc Piechaczyk
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

7.  High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.

Authors:  Claudia Volpi; Francesca Fallarino; Maria T Pallotta; Roberta Bianchi; Carmine Vacca; Maria L Belladonna; Ciriana Orabona; Antonella De Luca; Louis Boon; Luigina Romani; Ursula Grohmann; Paolo Puccetti
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 8.  Molecular control of steady-state dendritic cell maturation and immune homeostasis.

Authors:  Gianna Elena Hammer; Averil Ma
Journal:  Annu Rev Immunol       Date:  2013-01-17       Impact factor: 28.527

9.  SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.

Authors:  Ciriana Orabona; Maria T Pallotta; Claudia Volpi; Francesca Fallarino; Carmine Vacca; Roberta Bianchi; Maria L Belladonna; Maria C Fioretti; Ursula Grohmann; Paolo Puccetti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

10.  Foal monocyte-derived dendritic cells become activated upon Rhodococcus equi infection.

Authors:  M Julia B F Flaminio; Daryl V Nydam; Hélène Marquis; Mary Beth Matychak; Steeve Giguère
Journal:  Clin Vaccine Immunol       Date:  2008-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.